Skip to main content



Local Cdiff information for Florida

Florida

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Florida.



Local Cdiff information for Florida

Florida

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Florida.

Providers

Dr. Alison Schneider, MD

Cleveland Clinic Florida
2950 Cleveland Clinic Blvd
Weston, 33331
(954) 659-5646
FMT Provider: Yes
VISIT WEBSITE >

Dr. Lawrence Rothman, MD

Gastro Health
9408 SW 87th Ave, Suite 200
Miami, 33176
305-913-0666
FMT Provider: Yes
VISIT WEBSITE >

Dr. R. David Shepherd, MD

Florida Medical Clinic
4224 N Tampania Ave
Tampa, 33607
813-280-7111
FMT Provider: Yes
VISIT WEBSITE >

Dr. Katherine Kosche, MD, PhD

Gastro Health
12251 Taft Street
Suite 401
Pembroke Pines, 33026
(954) 433-5900
EMAIL DR. KOSCHE >
FMT Provider: Yes
VISIT WEBSITE >

Dr. Sovi Joseph, MD

3440 Tamiami Trail
Suite 1
Port Charlotte, 33952
(941) 258-9500
FMT Provider: Yes
VISIT WEBSITE >

Dr. Lawrence Fiedler, MD

Gastro Health
2300 Glades Road
Suite 201E
Boca Raton, 33431
(561) 208-2121
EMAIL DR. FIELDLER >
FMT Provider: Yes
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 5269
Hospital Onset: 5269
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.60
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: No
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
STATUTE >

State Contact

A.C. (Anne-Carol) Burke, M.A.
Healthcare-associated Infection Prevention Program Manager
Florida Department of Health
Bureau of Epidemiology
4052 Bald Cypress Way
Tallahassee, 32399
850-766-7547
EMAIL A.C. (ANNE-CAROL) BURKE, M.A. >

CLINICAL TRIALS

FMT National Registry

Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
EMAIL
Gender: All
Age: All ages

OpTION

Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
EMAIL
Gender: All
Age: 18 Years and older

ROAR

Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
EMAIL
Gender: All
Age: 18 Years and older

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.

To Understand the Safety and Effects of a C. Difficile Vaccine

Official Title: A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, Immunogenicity, and Immunopersistence of a Clostridioides Difficile Vaccine Administered in a 2-Dose Regimen With Novel Adjuvants in Healthy Adults
Trial No. NCT05805826
Type: Interventional
Recruitment: Recruiting
Sponsor: Pfizer
Contact: Pfizer CT.gov Call Center
EMAIL >
Gender: All
Age: 65 Years and older